Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPINK5 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | ITGB5 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | XKRX | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | ZNF440 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | SSX2IP | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | POLE | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | HSCB | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | SLC16A10 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | GUCA1B | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |